Recommended Oral Contraceptive for Continuous Use in Canada
For a young woman experiencing persistent breakthrough bleeding and cramping on Lolo (low-dose ethinyl estradiol/levonorgestrel), I recommend switching to a monophasic combined oral contraceptive containing 30-35 μg ethinyl estradiol with levonorgestrel or norgestimate, taken continuously without hormone-free intervals. 1
Rationale for Higher Estrogen Dose
The primary issue with Lolo is its ultra-low estrogen content (20 μg ethinyl estradiol), which commonly causes breakthrough bleeding and spotting, especially with continuous use. 2 Unscheduled bleeding is most common during the first 3-6 months of extended or continuous combined hormonal contraceptive use and generally decreases with continued use, but switching to a higher estrogen dose often resolves persistent bleeding issues. 2
Specific Product Recommendations for Canada:
- First choice: Monophasic COC with 30-35 μg ethinyl estradiol + levonorgestrel or norgestimate 1
- These formulations provide better cycle control than ultra-low-dose pills when used continuously
- The higher estrogen dose provides superior endometrial stability, reducing breakthrough bleeding 2
Management of Continuous Use
When prescribing for continuous use, counsel the patient that:
- Breakthrough bleeding typically improves after the first 3-6 months of continuous use 2
- If breakthrough bleeding persists beyond 3-6 months, a planned 3-4 day hormone-free interval can be implemented (but not during the first 21 days of use and not more than once per month) 2
- Rule out underlying gynecological problems if bleeding persists: inconsistent use, drug interactions, smoking, STDs, pregnancy, or uterine pathology (polyps, fibroids) 2
Benefits of Continuous Regimens
Extended or continuous cycles are particularly appropriate for patients with:
- Severe dysmenorrhea (cramping) - which this patient is experiencing 1
- Abnormal uterine bleeding 1
- Conditions exacerbated cyclically (migraine without aura, endometriosis) 1
- Desire for amenorrhea 1
Continuous regimens optimize ovarian suppression by eliminating hormone-free intervals, potentially increasing contraceptive effectiveness, especially in young women who may miss pills. 1
Common Pitfall to Avoid
Do not continue the same ultra-low-dose formulation (20 μg ethinyl estradiol) expecting bleeding to resolve with time alone. While breakthrough bleeding can improve with continued use of any formulation 2, this patient has already been using Lolo with persistent symptoms, indicating the estrogen dose is insufficient for her endometrial stability needs. The 30-35 μg formulations provide better cycle control for continuous use. 1
Alternative if Oral Route Undesired
If the patient prefers non-oral options for continuous use, the contraceptive vaginal ring (NuvaRing) can be used continuously by replacing monthly (rings contain sufficient medication for up to 35 days of use). 3 However, given her request specifically for an OCP, the higher-dose monophasic pill remains the optimal recommendation.